Philip Chi Lip Kwok (Philip C L Kwok)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Topics

Pulmonary Tuberculosis

Acinetobacter Baumannii

Top Venues

Pharmaceutical research

Antibiotics (Basel, Switzerland)

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Grace Tsz Yan Yau, Waiting Tai, Jonathon Carl Arnold, Hak-Kim Chan, Philip Chi Lip Kwok
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration. Pharmaceutical research (2023)
Grace Tsz Yan Yau, Waiting Tai, Jonathon Carl Arnold, Hak-Kim Chan, Philip Chi Lip Kwok
Cannabidiol for the Treatment of Brain Disorders: Therapeutic Potential and Routes of Administration. Pharmaceutical research (2023)
Chengxi Liu, Qixuan Hong, Rachel Yoon Kyung Chang, Philip Chi Lip Kwok, Hak-Kim Chan
Phage-Antibiotic Therapy as a Promising Strategy to Combat Multidrug-Resistant Infections and to Enhance Antimicrobial Efficiency. Antibiotics (Basel, Switzerland) 11 (5) (2022)
Waiting Tai, Philip Chi Lip Kwok
Recent advances in drug delivery to the central nervous system by inhalation. Expert opinion on drug delivery 19 (5) (2022)
Waiting Tai, Michael Yee Tak Chow, Rachel Yoon Kyung Chang, Patricia Tang, Igor Gonda, Robert B MacArthur, Hak-Kim Chan, Philip Chi Lip Kwok
Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19. Pharmaceutics 13 (8) (2021)
Zitong Shao, Waiting Tai, Yingshan Qiu, Rico C H Man, Qiuying Liao, Michael Y T Chow, Philip Chi Lip Kwok, Jenny Ka Wing Lam
Spray-Dried Powder Formulation of Capreomycin Designed for Inhaled Tuberculosis Therapy. Pharmaceutics 13 (12) (2021)
Rachel Yoon Kyung Chang, Philip Chi Lip Kwok, Sussan Ghassabian, John D Brannan, Heikki Olavi Koskela, Hak-Kim Chan
Cough as an adverse effect on inhalation pharmaceutical products. British journal of pharmacology 177 (18) (2020)
Theerthankar Das, Huai-Jin Choong, Yee Chin Kwang, Hak-Kim Chan, Jim Manos, Philip Chi Lip Kwok, Hien T T Duong
Spray-Dried Particles of Nitric Oxide-Modified Glutathione for the Treatment of Chronic Lung Infection. Molecular pharmaceutics 16 (4) (2019)